Midlife women making hormone therapy decisions

Women's Health Issues

Volumn 11, Issue 3, 2001, Pages 216-230

  MacLaren, Aileen ^a   Woods, Nancy Fugate ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ADULT; AGE; ARTICLE; DECISION MAKING; DEMOGRAPHY; DIET SUPPLEMENTATION; DOCTOR PATIENT RELATION; EDUCATION; FEMALE; HEALTH CARE; HEALTH INSURANCE; HEALTH PRACTITIONER; HEALTH STATUS; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; MENOPAUSE; PATIENT INFORMATION; PHYSICIAN; POSTMENOPAUSE OSTEOPOROSIS; RACE; SAMPLE; SYMPTOM;

ADULT; AGED; DECISION MAKING; FEMALE; HEALTH SURVEYS; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; PATIENT EDUCATION; UNITED STATES; WOMEN'S HEALTH;

EID: 0035032867     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1049-3867(01)00082-2     Document Type: Article

References (55)

1. Population-based strategy for improving informed decision-making about hormone replacement therapy in managed care settings
2. Medicalization of women's third age
3. Hormone replacement therapy
4. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women
5. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
6. Estrogen replacement therapy and fractures in older women. Study of Osteoperotic Fractures Research Group
7. Hormone therapy to prevent disease and prolong life in postmenopausal women
8. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
9. Use of hormone replacement therapy by postmenopausal women in the United States
10. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/Progestin Replacement Study
11. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
12. Use of estrogen plus progestin is associated with greater increase in breast cancer risk than estrogen alone
13. Breast cancer and hormone replacement therapy; collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
14. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
15. The effect of raloxifene on risk of breast cancer in postmenopausal women; Results from the MORE randomized trial
16. Hormone and nonhormone therapy for the maintenance of postmenopausal health; the need for randomized controlled trials of estrogen and raloxifene
17. Use of postmenopausal hormone replacement therapy; estimates from a nationally representative cohort study
18. Menopause-different meanings for different women
19. Breast cancer risk factors and screening; United States, 1987
20. Low rates of hormone replacement in visits to United States primary care physicians
21. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women
22. Prevalence and determinants of estrogen replacement therapy in elderly women
23. Correlates of postmenopausal estrogen use and trends throughout the 1980's in two southeastern New England communities
24. Characteristics of menopausal women; a survey of King and Pierce counties in Washington, 1973-1974
25. Hormone replacement therapy; characteristics of users and non-users in a British general practice cohort identified through computerized prescribing records
26. Attitudes of low-income clinic patients toward menopause
27. Menopause and hormone replacement therapy; focus groups of African American and Caucasian women
28. African American women's attitudes and expectations of menopause
29. Timing of postmenopausal estrogen for optimal bone mineral density; The Rancho Bernardo Study
30. Women's beliefs and decisions about hormone replacement therapy
31. NAMS-Gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy
32. Hormone use among middle-aged women; results of a 3 year study. Menopause
33. Risk factors associated with women's compliance with estrogen replacement therapy
34. Can we improve compliance with long term HRT?
35. Estrogen replacement therapy; a survey of women's knowledge and attitudes
36. Compliance with hormone replacement therapy
37. Enhancing patient compliance with hormone replacement therapy at menopause
38. Prevalence, initiation and continuation of hormone replacement therapy
39. An overview of estrogen replacement therapy in postmenopausal women
40. Primary care and patient perceptions of access to care
41. The association of attributes of primary care with the delivery of clinical preventive services
42. Primary care and receipt of preventive services
43. Deciding about using hormone therapy for preventing diseases of advanced age; women's models and implications for health care and decision support
44. An educational intervention as decision support for menopausal women
45. A decision aid for women considering hormone therapy after menopause; decision support framework and evaluation
46. Decision aids for patients facing health treatment or screening decisions; systematic review
47. Preparation for menopause prospective evaluation of a health education intervention for middle-aged women
48. Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy